Eduard H. Panosyan - Concepedia

Author

Eduard H. Panosyan

UCLA Medical Center ORCID

Also Known As

B. Tyler, E. H. Panosyan, EDUARD H. PANOSYAN, Eduard H Panosyan, Eduard H. Panosyan, Eduard Panosyan

Publications

Citations

H-Index

Concepts

All Affiliations

UCLA Medical Center University of California, Los Angeles Harbor–UCLA Medical Center Children's Hospital of Los Angeles The Lundquist Institute

About

Eduard H. Panosyan is an author at UCLA Medical Center specializing in medicine, glioma, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	546
2	Health Sciences	3	3	332
3	Engineering	1	1	110
4	Allergy	1	1	231
5	Biomedical Engineering	1	1	110

Eduard H. Panosyan

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
A Phase 3 Trial of <scp>l</scp> -Glutamine in Sickle Cell Disease Yutaka Niihara, Scott T. Miller, Julie Kanter, New England Journal of Medicine	2018	522
Asparaginase Antibody and Asparaginase Activity in Children With Higher-Risk Acute Lymphoblastic Leukemia Eduard H. Panosyan, Nita L. Seibel, Sagrario Martín‐Aragón, Journal of Pediatric Hematology/Oncology Asparaginase ActivityImmunohematologyAnti-asparaginase AntibodyAllergyAb Titer	2004	231
In search of druggable targets for GBM amino acid metabolism Eduard H. Panosyan, Henry J. Lin, Jan Köster, BMC Cancer	2017	131
A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens Jing Sun, Michael Masterman‐Smith, Nicholas A. Graham, Cancer Research EngineeringAnalytical MicrosystemsOrgan-on-a-chipBiomedical EngineeringCancer Biology	2010	110
Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-Conjugated L-Asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia Douglas S. Hawkins, Julie R. Park, Blythe Thomson, Clinical Cancer Research	2004	109
A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells Koppany Visnyei, Hideyuki Onodera, Robert Damoiseaux, Molecular Cancer Therapeutics Gbm Stem CellsGbm ConsistHigh-grade GliomasCancer BiologyGlioma	2011	82
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Eduard H. Panosyan, Rita Grigoryan, Ioannis A. Avramis, PubMed	2004	75
Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors Eduard H. Panosyan, Yuntao Wang, Peng Xia, Molecular Cancer Research	2014	69
Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Joseph L. Lasky, Eduard H. Panosyan, Ashley Plant, PubMed Pediatric Brain TumorsImmunologyImmunoeditingImmunotherapeuticsHigh-grade Gliomas	2013	67
Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961). Rita Grigoryan, Eduard H. Panosyan, Nita L. Seibel, PubMed	2004	55

Page 1